Politics
Wuhan Institute of Virology and Chinese army submit patent for Gilead anti-ebola drug to fight coronavirus
China is attempting to obtain a patent for Gilead Sciences’ experimental coronavirus drug, according to a recent report by Bloomberg. The drug, known as remdesivir, has shown promise in treating the virus and is currently being tested in clinical trials. However, Gilead holds the patent for the drug in the United States and other countries, and it is unclear if China will be successful in obtaining a patent for it. The situation highlights the ongoing tension between China and other countries over intellectual property rights.
